Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.
Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine...
FDA to Ardelyx: “Give us a Couple More Weeks.” (ARDX) $1.80.
Oh boy, another day, another snag. There goes our Christmas bonus, dang.
LIVE QUOTE
It's been...
Killer, 44-Page Report on GeoVax (GOVX).
And a Nine-Page Summary Report..Great Weekend Reading.
This is one killer report. In fact if we might be so...
SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations
Washington D.C., Aug. 20, 2019 —
The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered...
Initiating Coverage on Mitesco (MITI) FKA True Nature Holdings (TNTY) $0.02. Adding to Watch...
Click here to download.
Biotech’s Turning Up…
Biotech Sector Gains Near 10% in Past Month, After Biogen (BIIB) Reports Breaking News.
We keep telling investors...
Pivotal Clinical Trials: Frequently Asked Questions (Sofpromed).
What is a pivotal clinical trial?
A pivotal clinical trial is a clinical study seeking...
Preventing Type I Diabetes. Here’s How Provention (PRVB) Works.
Here's How Provention's Treatment Works.
Interview With an Actual Provention Bio (PRVB) Clinical Trial Participant.
Video: Okay, You Tested Positive for Corona, Now What?
https://youtu.be/vN30emwcNS4
Professor Roger Seheult,...
The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).
Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!